These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 19125887)

  • 1. T-cell receptor binding affinities and kinetics: impact on T-cell activity and specificity.
    Stone JD; Chervin AS; Kranz DM
    Immunology; 2009 Feb; 126(2):165-76. PubMed ID: 19125887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering the binding properties of the T cell receptor:peptide:MHC ternary complex that governs T cell activity.
    Bowerman NA; Crofts TS; Chlewicki L; Do P; Baker BM; Christopher Garcia K; Kranz DM
    Mol Immunol; 2009 Sep; 46(15):3000-8. PubMed ID: 19595460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of TCR-binding properties and antigen presentation format on T cell responsiveness.
    Chervin AS; Stone JD; Holler PD; Bai A; Chen J; Eisen HN; Kranz DM
    J Immunol; 2009 Jul; 183(2):1166-78. PubMed ID: 19553539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The study of high-affinity TCRs reveals duality in T cell recognition of antigen: specificity and degeneracy.
    Donermeyer DL; Weber KS; Kranz DM; Allen PM
    J Immunol; 2006 Nov; 177(10):6911-9. PubMed ID: 17082606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A structural-based machine learning method to classify binding affinities between TCR and peptide-MHC complexes.
    Dhusia K; Su Z; Wu Y
    Mol Immunol; 2021 Nov; 139():76-86. PubMed ID: 34455212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposite effects of endogenous peptide-MHC class I on T cell activity in the presence and absence of CD8.
    Stone JD; Aggen DH; Chervin AS; Narayanan S; Schmitt TM; Greenberg PD; Kranz DM
    J Immunol; 2011 May; 186(9):5193-200. PubMed ID: 21451107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T Cell Receptor Engineering and Analysis Using the Yeast Display Platform.
    Smith SN; Harris DT; Kranz DM
    Methods Mol Biol; 2015; 1319():95-141. PubMed ID: 26060072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TCR affinity for p/MHC formed by tumor antigens that are self-proteins: impact on efficacy and toxicity.
    Stone JD; Harris DT; Kranz DM
    Curr Opin Immunol; 2015 Apr; 33():16-22. PubMed ID: 25618219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tricks with tetramers: how to get the most from multimeric peptide-MHC.
    Wooldridge L; Lissina A; Cole DK; van den Berg HA; Price DA; Sewell AK
    Immunology; 2009 Feb; 126(2):147-64. PubMed ID: 19125886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based design of a T-cell receptor leads to nearly 100-fold improvement in binding affinity for pepMHC.
    Haidar JN; Pierce B; Yu Y; Tong W; Li M; Weng Z
    Proteins; 2009 Mar; 74(4):948-60. PubMed ID: 18767161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymic selection generates T cells expressing self-reactive TCRs in the absence of CD45.
    Trop S; Charron J; Arguin C; Lesage S; Hugo P
    J Immunol; 2000 Sep; 165(6):3073-9. PubMed ID: 10975818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of TCRs with MHC-peptide complexes: a quantitative basis for mechanistic models.
    Margulies DH
    Curr Opin Immunol; 1997 Jun; 9(3):390-5. PubMed ID: 9203420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of peptide interaction with MHC creates TCR partial agonists.
    Ryan KR; McNeil LK; Dao C; Jensen PE; Evavold BD
    Cell Immunol; 2004 Jan; 227(1):70-8. PubMed ID: 15051516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of T cell function by TCR/pMHC binding kinetics.
    Carreño LJ; González PA; Kalergis AM
    Immunobiology; 2006; 211(1-2):47-64. PubMed ID: 16446170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping the stochastic sequence of individual ligand-receptor binding events to cellular activation: T cells act on the rare events.
    Lin JJY; Low-Nam ST; Alfieri KN; McAffee DB; Fay NC; Groves JT
    Sci Signal; 2019 Jan; 12(564):. PubMed ID: 30647147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ca2+ release from the endoplasmic reticulum of NY-ESO-1-specific T cells is modulated by the affinity of TCR and by the use of the CD8 coreceptor.
    Chen JL; Morgan AJ; Stewart-Jones G; Shepherd D; Bossi G; Wooldridge L; Hutchinson SL; Sewell AK; Griffiths GM; van der Merwe PA; Jones EY; Galione A; Cerundolo V
    J Immunol; 2010 Feb; 184(4):1829-1839. PubMed ID: 20053942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Threshold signaling of human Th0 cells in activation and anergy: modulation of effector function by altered TCR ligand.
    Verhoef A; Lamb JR
    J Immunol; 2000 Jun; 164(11):6034-40. PubMed ID: 10820288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct footprints of TCR engagement with highly homologous ligands.
    Santori FR; Holmberg K; Ostrov D; Gascoigne NR; Vukmanović S
    J Immunol; 2004 Jun; 172(12):7466-75. PubMed ID: 15187125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral "CD8 tuning" dynamically modulates the size and responsiveness of an antigen-specific T cell pool in vivo.
    Maile R; Siler CA; Kerry SE; Midkiff KE; Collins EJ; Frelinger JA
    J Immunol; 2005 Jan; 174(2):619-27. PubMed ID: 15634879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly cross-reactive T cell responses to myelin basic protein epitopes reveal a nonpredictable form of TCR degeneracy.
    Loftus C; Huseby E; Gopaul P; Beeson C; Goverman J
    J Immunol; 1999 Jun; 162(11):6451-7. PubMed ID: 10352259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.